{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:01:03Z","timestamp":1793325663238,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T00:00:00Z","timestamp":1697155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s11154-023-09845-x","type":"journal-article","created":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T02:01:32Z","timestamp":1697162492000},"page":"1205-1216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"24","author":[{"given":"Elena","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilda","family":"Guizzardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Canali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gaino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Costantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gherardo","family":"Mazziotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Uccella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Di Tommaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ferreli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Malvezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Spriano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mercante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,13]]},"reference":[{"issue":"1","key":"9845_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7\u201333. Epub 2022 Jan 12. PMID: 35020204.","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"9845_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","volume":"9","author":"A Miranda-Filho","year":"2021","unstructured":"Miranda-Filho A, Lortet-Tieulent J, Bray F, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021;9(4):225\u201334. https:\/\/doi.org\/10.1016\/S2213-8587(21)00027-9. Epub 2021 Mar 1. PMID: 33662333.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"5","key":"9845_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0002-9343(94)90321-2","volume":"97","author":"EL Mazzaferri","year":"1994","unstructured":"Mazzaferri EL, Jhiang SM. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994;97(5):418\u201328. https:\/\/doi.org\/10.1016\/0002-9343(94)90321-2. Erratum in: Am J Med 1995;98(2):215. PMID: 7977430.","journal-title":"Am J Med"},{"issue":"1","key":"9845_CR4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1210\/jc.2005-1322","volume":"91","author":"CF Eustatia-Rutten","year":"2006","unstructured":"Eustatia-Rutten CF, Corssmit EP, Biermasz NR, et al. Survival and death causes in differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2006;91(1):313\u20139. https:\/\/doi.org\/10.1210\/jc.2005-1322. Epub 2005 Nov 1. PMID: 16263822.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"9845_CR5","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/S0039-6060(98)70034-0","volume":"104","author":"B Cady","year":"1988","unstructured":"Cady B, Rossi R. An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery. 1988;104(6):947\u201353. PMID: 3194846.","journal-title":"Surgery"},{"issue":"6","key":"9845_CR6","first-page":"1088","volume":"102","author":"ID Hay","year":"1987","unstructured":"Hay ID, Grant CS, Taylor WF, et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: a retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery. 1987;102(6):1088\u201395. PMID: 3686348.","journal-title":"Surgery"},{"issue":"6","key":"9845_CR7","first-page":"1050","volume":"114","author":"ID Hay","year":"1993","unstructured":"Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery. 1993;114(6):1050\u20137. discussion 1057-8. PMID: 8256208.","journal-title":"Surgery"},{"issue":"Suppl 1","key":"9845_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10875-012-9847-0","volume":"33","author":"J Candido","year":"2013","unstructured":"Candido J, Hagemann T. Cancer-related inflammation. J Clin Immunol. 2013;33(Suppl 1):79\u201384. https:\/\/doi.org\/10.1007\/s10875-012-9847-0. Epub 2012 Dec 9. PMID: 23225204.","journal-title":"J Clin Immunol"},{"key":"9845_CR9","doi-asserted-by":"publisher","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002 Dec 19\u201326;420(6917):860-7. https:\/\/doi.org\/10.1038\/nature01322. PMID: 12490959; PMCID: PMC2803035.","DOI":"10.1038\/nature01322"},{"issue":"1","key":"9845_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nrc1782","volume":"6","author":"KE de Visser","year":"2006","unstructured":"de Visser KE, Eichten A, Coussens LM. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer. 2006;6(1):24\u201337. https:\/\/doi.org\/10.1038\/nrc1782. PMID: 16397525.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"9845_CR11","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.3390\/cancers6031670","volume":"6","author":"T Chanmee","year":"2014","unstructured":"Chanmee T, Ontong P, Konno K, Itano N. Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel). 2014;6(3):1670\u201390. https:\/\/doi.org\/10.3390\/cancers6031670. PMID: 25125485; PMCID: PMC4190561.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"9845_CR12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.ejso.2018.02.209","volume":"44","author":"A Dupr\u00e9","year":"2018","unstructured":"Dupr\u00e9 A, Malik HZ. Inflammation and cancer: what a surgical oncologist should know. Eur J Surg Oncol. 2018;44(5):566\u201370. https:\/\/doi.org\/10.1016\/j.ejso.2018.02.209. Epub 2018 Mar 2. PMID: 29530345.","journal-title":"Eur J Surg Oncol"},{"key":"9845_CR13","doi-asserted-by":"publisher","unstructured":"Ozmen S, Timur O, Calik I, Altinkaynak K, Simsek E, Gozcu H, Arslan A, Carlioglu A. Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer. Endocr Regul. 2017;51(3):131\u2013136. https:\/\/doi.org\/10.1515\/enr-2017-0013. PMID: 28858848.","DOI":"10.1515\/enr-2017-0013"},{"issue":"3","key":"9845_CR14","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s12020-013-0089-6","volume":"46","author":"JY Kim","year":"2014","unstructured":"Kim JY, Park T, Jeong SH, et al. Prognostic importance of baseline neutrophil to lymphocyte ratio in patients with advanced papillary thyroid carcinomas. Endocrine. 2014;46(3):526\u201331. https:\/\/doi.org\/10.1007\/s12020-013-0089-6. Epub 2013 Nov 23. PMID: 24272600.","journal-title":"Endocrine"},{"issue":"6","key":"9845_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.6061\/clinics\/2016(06)04","volume":"71","author":"W Gong","year":"2016","unstructured":"Gong W, Yang S, Yang X, et al. Blood preoperative neutrophil-to-lymphocyte ratio is correlated with TNM stage in patients with papillary thyroid cancer. Clin (Sao Paulo). 2016;71(6):311\u20134. https:\/\/doi.org\/10.6061\/clinics\/2016(06)04. PMID: 27438563; PMCID: PMC4930667.","journal-title":"Clin (Sao Paulo)"},{"issue":"5","key":"9845_CR16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/jso.23270","volume":"107","author":"CL Liu","year":"2013","unstructured":"Liu CL, Lee JJ, Liu TP, et al. Blood neutrophil-to-lymphocyte ratio correlates with tumor size in patients with differentiated thyroid cancer. J Surg Oncol. 2013;107(5):493\u20137. https:\/\/doi.org\/10.1002\/jso.23270. Epub 2012 Sep 20. PMID: 22996403.","journal-title":"J Surg Oncol"},{"key":"9845_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jss.2019.09.034","volume":"246","author":"M Yokota","year":"2020","unstructured":"Yokota M, Katoh H, Nishimiya H, et al. Lymphocyte-monocyte ratio significantly predicts recurrence in papillary thyroid Cancer. J Surg Res. 2020;246:535\u201343. https:\/\/doi.org\/10.1016\/j.jss.2019.09.034. Epub 2019 Nov 9. PMID: 31711613.","journal-title":"J Surg Res"},{"issue":"2","key":"9845_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s12020-020-02328-y","volume":"70","author":"K Kim","year":"2020","unstructured":"Kim K, Pak K, Kim IJ, et al. Lymphocyte-to-monocyte ratio prior to radioiodine ablation in low- and intermediate-risk, papillary thyroid cancer. Endocrine. 2020;70(2):364\u201371. https:\/\/doi.org\/10.1007\/s12020-020-02328-y. Epub 2020 May 5. PMID: 32372305.","journal-title":"Endocrine"},{"key":"9845_CR19","doi-asserted-by":"publisher","first-page":"8451","DOI":"10.2147\/CMAR.S219163","volume":"11","author":"L Song","year":"2019","unstructured":"Song L, Zhu J, Li Z, et al. The prognostic value of the lymphocyte-to-monocyte ratio for high-risk papillary thyroid carcinoma. Cancer Manag Res. 2019;11:8451\u201362. https:\/\/doi.org\/10.2147\/CMAR.S219163. PMID: 31572000; PMCID: PMC6756579.","journal-title":"Cancer Manag Res"},{"issue":"40","key":"9845_CR20","doi-asserted-by":"publisher","first-page":"e5079","DOI":"10.1097\/MD.0000000000005079","volume":"95","author":"K Jiang","year":"2016","unstructured":"Jiang K, Lei J, Chen W, et al. Association of the preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with lymph node metastasis and recurrence in patients with medullary thyroid carcinoma. Med (Baltim). 2016;95(40):e5079. https:\/\/doi.org\/10.1097\/MD.0000000000005079. PMID: 27749581; PMCID: PMC5059084.","journal-title":"Med (Baltim)"},{"issue":"3","key":"9845_CR21","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/jso.24683","volume":"116","author":"K Jiang","year":"2017","unstructured":"Jiang K, Lei J, Li C, et al. Comparison of the prognostic values of selected inflammation based scores in patients with medullary thyroid carcinoma: a pilot study. J Surg Oncol. 2017;116(3):281\u20137. https:\/\/doi.org\/10.1002\/jso.24683. Epub 2017 May 29. PMID: 28556902.","journal-title":"J Surg Oncol"},{"issue":"4","key":"9845_CR22","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3803\/EnM.2015.30.4.494","volume":"30","author":"SM Kim","year":"2015","unstructured":"Kim SM, Kim EH, Kim BH, et al. Association of the preoperative neutrophil-to-ymphocyte count ratio and platelet-to-lymphocyte count ratio with clinicopathological characteristics in patients with papillary thyroid Cancer. Endocrinol Metab (Seoul). 2015;30(4):494\u2013501. Epub 2015 Sep 10. PMID: 26354491; PMCID: PMC4722404.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"9845_CR23","doi-asserted-by":"publisher","unstructured":"Huang Y, Liu Y, Mo G et al. Inflammation markers have important value in Predicting Relapse in patients with papillary thyroid carcinoma: a long-term Follow-Up Retrospective Study. Cancer Control 2022 Jan-Dec;29:10732748221115236. https:\/\/doi.org\/10.1177\/10732748221115236. PMID: 35833862; PMCID: PMC9290143.","DOI":"10.1177\/10732748221115236"},{"issue":"7","key":"9845_CR24","doi-asserted-by":"publisher","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6(7):e1000100. https:\/\/doi.org\/10.1371\/journal.pmed.1000100","journal-title":"PLoS Med"},{"issue":"9","key":"9845_CR25","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1046\/j.1445-2197.2003.02748.x","volume":"73","author":"K Slim","year":"2003","unstructured":"Slim K, Nini E, Forestier D, et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument. ANZ J Surg. 2003;73(9):712\u20136.","journal-title":"ANZ J Surg"},{"key":"9845_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1745-6215-8-16","volume":"8","author":"JF Tierney","year":"2007","unstructured":"Tierney JF, Stewart LA, Ghersi D, et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007;8:16. https:\/\/doi.org\/10.1186\/1745-6215-8-16. PMID: 17555582; PMCID: PMC1920534.","journal-title":"Trials"},{"issue":"1","key":"9845_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2307\/3001666","volume":"10","author":"WG Cochran","year":"1954","unstructured":"Cochran WG. The combination of estimates from different experiments. Biometrics. 1954;10(1):101\u201329.","journal-title":"Biometrics"},{"key":"9845_CR28","doi-asserted-by":"crossref","unstructured":"Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med. 2012;31(29):3805-20. doi: 10.1002\/sim.5453. Epub 2012 Jul 4. PMID: 22763950; PMCID: PMC3546377.","DOI":"10.1002\/sim.5453"},{"issue":"2","key":"9845_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/jrsm.11","volume":"1","author":"W Viechtbauer","year":"2010","unstructured":"Viechtbauer W, Cheung MW. Outlier and influence diagnostics for meta-analysis. Res Synth Methods. 2010;1(2):112\u201325. https:\/\/doi.org\/10.1002\/jrsm.11. Epub 2010 Oct 4. PMID: 26061377.","journal-title":"Res Synth Methods"},{"issue":"7109","key":"9845_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629\u201334. https:\/\/doi.org\/10.1136\/bmj.315.7109.629. PMID: 9310563; PMCID: PMC2127453.","journal-title":"BMJ"},{"key":"9845_CR31","doi-asserted-by":"publisher","unstructured":"Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56(2):455 \u2013 63. https:\/\/doi.org\/10.1111\/j.0006-341x.2000.00455.x. PMID: 10877304.","DOI":"10.1111\/j.0006-341x.2000.00455.x"},{"key":"9845_CR32","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.2147\/CMAR.S239296","volume":"12","author":"W Chen","year":"2020","unstructured":"Chen W, Wei T, Li Z, et al. Association of the preoperative inflammation-based scores with TNM Stage and recurrence in patients with papillary thyroid carcinoma: a Retrospective, Multicenter Analysis. Cancer Manag Res. 2020;12:1809\u201318. PMID: 32210623; PMCID: PMC7073431.","journal-title":"Cancer Manag Res"},{"key":"9845_CR33","doi-asserted-by":"publisher","unstructured":"Lang BH, Ng CP, Au KB et al. Does preoperative neutrophil lymphocyte ratio predict risk of recurrence and occult central nodal metastasis in papillary thyroid carcinoma? World J Surg. 2014;38(10):2605-12. https:\/\/doi.org\/10.1007\/s00268-014-2630-z. PMID: 24809487.","DOI":"10.1007\/s00268-014-2630-z"},{"issue":"2","key":"9845_CR34","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4174\/astr.2019.96.2.70","volume":"96","author":"KH Lee","year":"2019","unstructured":"Lee KH, Seok EY, Kim EY, et al. Different prognostic values of individual hematologic parameters in papillary thyroid cancer due to age-related changes in immunity. Ann Surg Treat Res. 2019;96(2):70\u20137. https:\/\/doi.org\/10.4174\/astr.2019.96.2.70. Epub 2018 Jan 30. PMID: 30746354; PMCID: PMC6358596.","journal-title":"Ann Surg Treat Res"},{"issue":"1","key":"9845_CR35","doi-asserted-by":"publisher","first-page":"31","DOI":"10.14639\/0392-100X-N1089","volume":"41","author":"C Offi","year":"2021","unstructured":"Offi C, Romano RM, Cangiano A, et al. Clinical significance of neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, platelet-to-lymphocyte ratio and prognostic nutritional index in low-risk differentiated thyroid carcinoma. Acta Otorhinolaryngol Ital. 2021;41(1):31\u20138. https:\/\/doi.org\/10.14639\/0392-100X-N1089. PMID: 33746220; PMCID: PMC7982751.","journal-title":"Acta Otorhinolaryngol Ital"},{"key":"9845_CR36","doi-asserted-by":"publisher","first-page":"e3022","DOI":"10.6061\/clinics\/2021\/e3022","volume":"76","author":"CM Riguetto","year":"2021","unstructured":"Riguetto CM, Barreto IS, Maia FFR, et al. Usefulness of pre-thyroidectomy neutrophil-lymphocyte, platelet-lymphocyte, and monocyte-lymphocyte ratios for discriminating lymph node and distant metastases in differentiated thyroid cancer. Clin (Sao Paulo). 2021;76:e3022. https:\/\/doi.org\/10.6061\/clinics\/2021\/e3022. PMID: 34406270; PMCID: PMC8341041.","journal-title":"Clin (Sao Paulo)"},{"issue":"5","key":"9845_CR37","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/jso.26089","volume":"122","author":"L Zhang","year":"2020","unstructured":"Zhang L, Luo H, Wang L, et al. Diagnostic and prognostic value of preoperative systemic inflammatory markers in anaplastic thyroid cancer. J Surg Oncol. 2020;122(5):897\u2013905. https:\/\/doi.org\/10.1002\/jso.26089. Epub 2020 Jun 28. PMID: 32596828.","journal-title":"J Surg Oncol"},{"key":"9845_CR38","doi-asserted-by":"publisher","unstructured":"Zhou C, Duan D, Liu S. Predictive value of a Prognostic Model based on lymphocyte-to-monocyte ratio before Radioiodine Therapy for recurrence of papillary thyroid carcinoma. Technol Cancer Res Treat 2021 Jan-Dec 20:15330338211027910. https:\/\/doi.org\/10.1177\/15330338211027910. PMID: 34191658; PMCID: PMC8252333.","DOI":"10.1177\/15330338211027910"},{"issue":"1","key":"9845_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2016;26(1):1\u2013133. https:\/\/doi.org\/10.1089\/thy.2015.0020. PMID: 26462967; PMCID: PMC4739132.","journal-title":"Thyroid"},{"issue":"7745","key":"9845_CR40","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41586-019-0915-y","volume":"566","author":"BM Szczerba","year":"2019","unstructured":"Szczerba BM, Castro-Giner F, Vetter M, et al. Neutrophils escort circulating tumour cells to enable cell cycle progression. Nature. 2019;566(7745):553\u20137. https:\/\/doi.org\/10.1038\/s41586-019-0915-y. Epub 2019 Feb 6. PMID: 30728496.","journal-title":"Nature"},{"issue":"8","key":"9845_CR41","doi-asserted-by":"publisher","first-page":"e22964","DOI":"10.1002\/jcla.22964","volume":"33","author":"J Liu","year":"2019","unstructured":"Liu J, Li S, Zhang S, Liu Y, Ma L, Zhu J, Xin Y, Wang Y, Yang C, Cheng Y. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. J Clin Lab Anal. 2019;33(8):e22964. https:\/\/doi.org\/10.1002\/jcla.22964. Epub 2019 Jul 8. PMID: 31282096; PMCID: PMC6805305.","journal-title":"J Clin Lab Anal"},{"issue":"6","key":"9845_CR42","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1053\/j.seminoncol.2023.01.006","volume":"49","author":"D Smith","year":"2022","unstructured":"Smith D, Raices M, Cayol F, Corvatta F, Caram L, Dietrich A. Is the neutrophil-to-lymphocyte ratio a prognostic factor in non-small cell lung cancer patients who receive adjuvant chemotherapy? Semin Oncol. 2022;49(6):482\u20139. https:\/\/doi.org\/10.1053\/j.seminoncol.2023.01.006. Epub 2023 Feb 6. PMID: 36775797.","journal-title":"Semin Oncol"},{"issue":"20","key":"9845_CR43","doi-asserted-by":"publisher","first-page":"e19686","DOI":"10.1097\/MD.0000000000019686","volume":"99","author":"J Feng","year":"2020","unstructured":"Feng J, Wang Y, Shan G, et al. Clinical and prognostic value of neutrophil-lymphocyte ratio for patients with thyroid cancer: a meta-analysis. Med (Baltim). 2020;99(20):e19686. https:\/\/doi.org\/10.1097\/MD.0000000000019686","journal-title":"Med (Baltim)"},{"issue":"4","key":"9845_CR44","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/ajco.12358","volume":"11","author":"S Gunduz","year":"2015","unstructured":"Gunduz S, Mutlu H, Tural D, et al. Platelet to lymphocyte ratio as a new prognostic for patients with metastatic renal cell cancer. Asia Pac J Clin Oncol. 2015;11(4):288\u201392. https:\/\/doi.org\/10.1111\/ajco.12358","journal-title":"Asia Pac J Clin Oncol"},{"key":"9845_CR45","doi-asserted-by":"publisher","first-page":"22618","DOI":"10.1038\/srep22618","volume":"6","author":"H Zhang","year":"2016","unstructured":"Zhang H, Gao L, Zhang B, et al. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: a systematic review and meta-analysis. Sci Rep. 2016;6:22618. https:\/\/doi.org\/10.1038\/srep22618","journal-title":"Sci Rep"},{"key":"9845_CR46","doi-asserted-by":"publisher","first-page":"1053125","DOI":"10.1155\/2017\/1053125","volume":"2017","author":"XZ Huang","year":"2017","unstructured":"Huang XZ, Chen WJ, Zhang X, et al. An elevated platelet-to-lymphocyte ratio predicts poor prognosis and clinicopathological characteristics in patients with colorectal Cancer: a Meta-analysis. Dis Markers. 2017;2017:1053125. https:\/\/doi.org\/10.1155\/2017\/1053125","journal-title":"Dis Markers"},{"key":"9845_CR47","doi-asserted-by":"publisher","unstructured":"Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res. 2002;22(9):913 \u2013 22. https:\/\/doi.org\/10.1089\/10799900260286623. PMID: 12396713.","DOI":"10.1089\/10799900260286623"},{"key":"9845_CR48","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cca.2018.04.023","volume":"483","author":"B Li","year":"2018","unstructured":"Li B, Zhou P, Liu Y, et al. Platelet-to-lymphocyte ratio in advanced Cancer: review and meta-analysis. Clin Chim Acta. 2018;483:48\u201356. https:\/\/doi.org\/10.1016\/j.cca.2018.04.023","journal-title":"Clin Chim Acta"},{"issue":"22","key":"9845_CR49","doi-asserted-by":"publisher","first-page":"31926","DOI":"10.18632\/oncotarget.7876","volume":"7","author":"L Gu","year":"2016","unstructured":"Gu L, Li H, Chen L, et al. Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis. Oncotarget. 2016;7(22):31926\u201342. https:\/\/doi.org\/10.18632\/oncotarget.7876","journal-title":"Oncotarget"},{"issue":"10","key":"9845_CR50","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.ctrv.2015.10.003","volume":"41","author":"TF Nishijima","year":"2015","unstructured":"Nishijima TF, Muss HB, Shachar SS, et al. Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis. Cancer Treat Rev. 2015;41(10):971\u20138. https:\/\/doi.org\/10.1016\/j.ctrv.2015.10.003. Epub 2015 Oct 23. PMID: 26481060.","journal-title":"Cancer Treat Rev"},{"issue":"6","key":"9845_CR51","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1089\/thy.2018.0684","volume":"29","author":"J Ahn","year":"2019","unstructured":"Ahn J, Song E, Oh HS, et al. Low lymphocyte-to-Monocyte Ratios are Associated with poor overall survival in anaplastic thyroid carcinoma patients. Thyroid. 2019;29(6):824\u20139. https:\/\/doi.org\/10.1089\/thy.2018.0684","journal-title":"Thyroid"},{"issue":"1","key":"9845_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/cen.14120","volume":"92","author":"J Ahn","year":"2020","unstructured":"Ahn J, Song E, Kim WG, et al. Prognostic role of the lymphocyte-to-monocyte ratio for clinical outcomes of patients with progressive radioiodine-refractory differentiated thyroid carcinoma treated by sorafenib. Clin Endocrinol (Oxf). 2020;92(1):71\u20136. https:\/\/doi.org\/10.1111\/cen.14120","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"9845_CR53","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S2213-8587(16)30277-7","volume":"5","author":"JD French","year":"2017","unstructured":"French JD, Bible K, Spitzweg C, Haugen BR, Ryder M. Leveraging the immune system to treat advanced thyroid cancers. Lancet Diabetes Endocrinol. 2017;5(6):469\u201381. https:\/\/doi.org\/10.1016\/S2213-8587(16)30277-7. Epub 2016 Oct 20. PMID: 27773653.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"9845_CR54","doi-asserted-by":"publisher","first-page":"62","DOI":"10.23736\/S2724-6507.20.03342-8","volume":"46","author":"C Colombo","year":"2021","unstructured":"Colombo C, Giancola N, Fugazzola L. Personalized treatment for differentiated thyroid cancer: current data and new perspectives. Minerva Endocrinol (Torino). 2021;46(1):62\u201389. https:\/\/doi.org\/10.23736\/S2724-6507.20.03342-8","journal-title":"Minerva Endocrinol (Torino)"}],"updated-by":[{"DOI":"10.1007\/s11154-023-09851-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000}}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-023-09845-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11154-023-09845-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-023-09845-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T07:09:41Z","timestamp":1701846581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11154-023-09845-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["9845"],"URL":"https:\/\/doi.org\/10.1007\/s11154-023-09845-x","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11154-023-09851-z","asserted-by":"object"}]},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,13]]},"assertion":[{"value":"6 October 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2023","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11154-023-09851-z","URL":"https:\/\/doi.org\/10.1007\/s11154-023-09851-z","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"N\/A.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}